4 results match your criteria: "Hebei Petrochina Central Hospital Langfang 065000[Affiliation]"
Am J Transl Res
December 2023
Department of Health Management Center, Zhongshan Hospital, Shanghai Medical College of Fudan University Shanghai 200032, China.
Objectives: The long-term trends in crude mortality rates (CMRs) and age-standardized mortality rates characterized by Segi's world standard population (ASMRWs) of DMSCT in Pudong New Area (PNA), Shanghai, were evaluated from 1973 to 2019, and the role of demographic and non-demographic factors in the mortality of diseases of the musculoskeletal system and connective tissue (DMSCT) was explored.
Methods: The PNA district has the largest population and area in Shanghai. Therefore, the mortality registration system of the PNA district was used to calculate and verify the number of deaths.
Am J Transl Res
August 2023
Department of Tumor Hepatology, Zibo Hospital of Traditional Chinese Medicine Zibo 255300, Shandong, China.
Objective: To investigate the clinical efficacy of Shixuan and Qiduan blood-letting therapy combined with Master Tung's Five-tiger Point (11.27) Scraping for patients with hematological malignancy and peripheral neuritis.
Methods: A total of 70 patients with hematological malignancy who were admitted to Langfang TCM Hospital between January 2020 and December 2022 for treating chemotherapy-induced peripheral neuritis were enrolled retrospectively.
Am J Transl Res
June 2022
Department of Orthopaedics, Hebei Petrochina Central Hospital Langfang 065000, Hebei, China.
Background: Osteoarthritis (OA), the most prevalent form of arthritis, which affects up to 15% of the adult population. The work presented in this paper focuses on the analysis of the publications on osteoimmunology of OA. The purpose of this paper is to provide inspiration for future research on osteoimmunology of OA.
View Article and Find Full Text PDFAm J Transl Res
May 2020
Department of Radiotherapy, Hebei Petrochina Central Hospital Langfang 065000, China.
Introduction: With the rapid development of immunotherapy in recent years, growing clinical evidence suggests that a combination of radiotherapy and immunotherapy could improve the abscopal response rates and increase survival. However, observations on abscopal effects in patients receiving radiotherapy alone are still very rare. This study reports a rare case of a patient with type B3 thymoma with multiple lung metastases, who received localized irradiation.
View Article and Find Full Text PDF